- Home
- SMBK vs RZLT Comparison
SMBK vs RZLT Comparison
Compare SMBK & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMBK
- RZLT
- Stock Information
- Founded
- SMBK N/A
- RZLT 2010
- Country
- SMBK United States
- RZLT United States
- Employees
- SMBK N/A
- RZLT N/A
- Industry
- SMBK Major Banks
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- SMBK Finance
- RZLT Health Care
- Exchange
- SMBK Nasdaq
- RZLT Nasdaq
- Market Cap
- SMBK 602.3M
- RZLT 626.4M
- IPO Year
- SMBK N/A
- RZLT N/A
- Fundamental
- Price
- SMBK $36.84
- RZLT $7.81
- Analyst Decision
- SMBK Buy
- RZLT Strong Buy
- Analyst Count
- SMBK 4
- RZLT 5
- Target Price
- SMBK $37.25
- RZLT $12.50
- AVG Volume (30 Days)
- SMBK 47.3K
- RZLT 842.7K
- Earning Date
- SMBK 10-20-2025
- RZLT 11-06-2025
- Dividend Yield
- SMBK 0.87%
- RZLT N/A
- EPS Growth
- SMBK 62.51
- RZLT N/A
- EPS
- SMBK 2.47
- RZLT N/A
- Revenue
- SMBK $178,959,000.00
- RZLT N/A
- Revenue This Year
- SMBK $22.86
- RZLT N/A
- Revenue Next Year
- SMBK $10.59
- RZLT N/A
- P/E Ratio
- SMBK $14.93
- RZLT N/A
- Revenue Growth
- SMBK 20.51
- RZLT N/A
- 52 Week Low
- SMBK $26.31
- RZLT $2.22
- 52 Week High
- SMBK $37.72
- RZLT $8.34
- Technical
- Relative Strength Index (RSI)
- SMBK 55.94
- RZLT 72.08
- Support Level
- SMBK $36.52
- RZLT $6.92
- Resistance Level
- SMBK $37.60
- RZLT $8.34
- Average True Range (ATR)
- SMBK 0.63
- RZLT 0.31
- MACD
- SMBK -0.04
- RZLT 0.02
- Stochastic Oscillator
- SMBK 39.29
- RZLT 64.31
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.